Page 287 - FINAL PROGRAMME 2017

P-599 Polymorphism on chromosome 21 does not affect ovarian reserve but clinical outcomes after in vitro fertilization treatments
C. Rubio LLuesa1, M. Cruz2, C. González-Ravina3, M. Fernández-Sánchez4, E. Oquiñena5, A. Requena6 1iGenomix SL, Preimplantation Genetic Diagnosis, Valencia, Spain
2IVI Madrid, IVF Laboratory, Madrid, Spain
3IVI Sevilla, Andrology Laboratory, Sevilla, Spain
4IVI Sevilla, Gynecologist, Sevilla, Spain 5Biokilab, Laboratory, Vitoria, Spain
6IVI Madrid, Gynecologist, Madrid, Spain
P-600 Mitochondrial DNA levels in euploid blastocysts and pregnancy outcome
H. Gomaa1, R. Baydoun1, I. Lapana1, S. Soliman2
1Newlife Fertility Center, Embryology, Mississauga, Canada 2NewLife Fertility Center, REI, Mississauga, Canada
P-601 Successful Polar Body-based Preimplantation genetic diagnosis for Fragile-X syndrome and Gaucher Disease
M. Bellavia1, S. Cuomo2, E. Crugnola3, M. Jemec1, L. Risch4, G. Filippini-Cattaneo3
1Procrea, Fertility Center, Lugano, Switzerland
2ProCrea, IVF Laboratory, Lugano, Switzerland
3Procrealab SA, Molecular Genetics Laboratory, Lugano, Switzerland
4Labormedizinisches Zentrum Dr Risch AG, Medizinische und Chemische Labordiagnostik, Bern-Liebefeld, Switzerland
P-602 Young poor responders: should we screen for FMR1 mutations and cytogenetic aberrations?
M.W. Christensen1, V. Poulsen2, K. Kirkegaard3, U.B. Jensen4, H.J. Ingerslev5 1Aarhus University, Clinical Medicine, Aarhus N, Denmark
2Aarhus University, Health, Aarhus, Denmark
3Horsens Hospital, Gynecology and Obstetrics, Horsens, Denmark
4Aarhus University Hospital, Clinical Genetics, Aarhus, Denmark 5Aarhus University, Clinical Medicine, Aarhus, Denmark
P-603 Actual levels of mosaicism detection by construct reference curves
Y. Qiu1, D. Chen1, P. Liu1, J. Xia1, Q. Shi1, L. Xie1, Z. Zhu1, F. Chen1, H. Jiang1 1BGI, R&D, Shenzhen, China
P-604 Clinical outcomes after transfer of embryos with low-level chromosomal mosaicism
C. Jiramongkolrat1, W. Suksalak1, S. Martkamchan1, S. Nabu1, S. Suwannasing1, K. Maneewas2, S. Chanchamroen2, W. Quangkananurug3
1Next Generation Genomic, Laboratory, Bangkok, Thailand 2Safe Fertility Center, Laboratory, Bangkok, Thailand 3Safe Fertility Center, Clinician, Bangkok, Thailand
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 287
POSTERS